Gold R, Schmied M, Giegerich G, Breitschopf H, Hartung H P, Toyka K V, Lassmann H
Department of Neurology, Julius-Maximilians-Universität Würzburg.
Lab Invest. 1994 Aug;71(2):219-25.
A number of enzymatic techniques have recently been developed to detect DNA fragmentation in apoptosis at the cellular level. However, since DNA fragmentation also occurs in cellular necrosis, we studied to which extent the use of DNA polymerase (nick translation) or terminal transferase (tailing) allows the differentiation between internucleosomal DNA degradation, typical for apoptosis, and the more random DNA destruction in necrosis.
We compared these techniques on in vitro and in vivo models for apoptotic or necrotic cell death. Apoptosis of thymocytes in vitro was induced by gamma-irradiation, necrosis by the cytotoxic action of antibody and complement. Cell death in vivo was examined on paraffin-embedded tissue material from animals with autoimmune encephalomyelitis that served as a model for apoptosis, or in kainic acid-induced nerve cell degeneration as a model for necrosis.
DNA fragmentation was visualized by the incorporation of labeled nucleotides into the nuclei of affected cells utilizing tailing or nick translation techniques. In the early stages of cell degeneration in vitro, cells undergoing apoptosis were preferentially labeled by tailing, whereas necrotic cells were identified by nick translation. Similarly, early stages of necrosis in vivo were preferentially detected by nick translation, whereas tailing was slightly more sensitive for the detection of apoptosis. Results obtained with these enzymatic techniques were in accord with the assessment of cell death by morphologic criteria. Both techniques could be applied in tissue samples even after prolonged fixation in paraformaldehyde if the sections were pretreated with proteinase K digestion.
Our studies show that both in situ nick translation and in situ tailing are useful in detecting DNA fragmentation in cell suspensions and tissue sections. These techniques may help to define the molecular mechanisms leading to cell death in experimental conditions and eventually in human tissue.
最近已开发出多种酶促技术来检测细胞水平凋亡中的DNA片段化。然而,由于DNA片段化也发生在细胞坏死过程中,我们研究了使用DNA聚合酶(缺口平移)或末端转移酶(加尾)在多大程度上能够区分凋亡特有的核小体间DNA降解与坏死中更随机的DNA破坏。
我们在凋亡或坏死性细胞死亡的体外和体内模型上比较了这些技术。体外胸腺细胞凋亡通过γ射线照射诱导,坏死通过抗体和补体的细胞毒性作用诱导。体内细胞死亡在患自身免疫性脑脊髓炎动物的石蜡包埋组织材料上进行检测,该材料作为凋亡模型,或在海藻酸诱导的神经细胞变性中作为坏死模型。
利用加尾或缺口平移技术将标记的核苷酸掺入受影响细胞的细胞核中,从而使DNA片段化可视化。在体外细胞变性的早期阶段,发生凋亡的细胞优先通过加尾标记,而坏死细胞通过缺口平移识别。同样,体内坏死的早期阶段优先通过缺口平移检测到,而加尾对凋亡检测的敏感性略高。用这些酶促技术获得的结果与通过形态学标准对细胞死亡的评估一致。如果切片用蛋白酶K消化预处理,即使在多聚甲醛中长时间固定后,这两种技术也可应用于组织样本。
我们的研究表明,原位缺口平移和原位加尾在检测细胞悬液和组织切片中的DNA片段化方面都很有用。这些技术可能有助于确定在实验条件下乃至最终在人体组织中导致细胞死亡的分子机制。